Publications by authors named "Maria Moeller"

Claim this Profile
R
Rapid Quantitative Point-Of-Care Diagnostic Test for Post COVID-19 Vaccination Antibody Monitoring.
Maria E Moeller, Frederik N Engsig, Melanie Bade, Jeppe Fock, Pearlyn Pah

Microbiol Spectr· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of commercially available immuno-magnetic agglutination in comparison to enzyme-linked immunosorbent assays for rapid point-of-care diagnostics of COVID-19.
Maria E Moeller, Jeppe Fock, Pearlyn Pah, Antia De La C Veras, Melanie Bade

J Med Virol· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Expression of a Chimeric Antigen Receptor in Multiple Leukocyte Lineages in Transgenic Mice.
Carmen S M Yong, Jennifer A Westwood, Jan Schröder, Anthony T Papenfuss, Bianca von Scheidt, Maria Moeller

PLoS One· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tumor ablation by gene-modified T cells in the absence of autoimmunity.
Leanne X J Wang, Jennifer A Westwood, Maria Moeller, Connie P M Duong, Wei-Zen Wei

Cancer Res· December 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sustained antigen-specific antitumor recall response mediated by gene-modified CD4+ T helper-1 and CD8+ T cells.
Maria Moeller, Michael H Kershaw, Rachel Cameron, Jennifer A Westwood, Joseph A Trapani

Cancer Res· December 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adoptive transfer of T cells modified with a humanized chimeric receptor gene inhibits growth of Lewis-Y-expressing tumors in mice.
Jennifer A Westwood, Mark J Smyth, Michele W L Teng, Maria Moeller, Joseph A Trapani

Proc Natl Acad Sci U S A· December 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adoptive transfer of gene-engineered CD4+ helper T cells induces potent primary and secondary tumor rejection.
Maria Moeller, Nicole M Haynes, Michael H Kershaw, Jacob T Jackson, Michele W L Teng

Blood· November 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gene modification strategies to induce tumor immunity.
Amanda Murphy, Jennifer A Westwood, Michele W L Teng, Maria Moeller, Phillip K Darcy

Immunity· April 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gene-engineered T cells as a superior adjuvant therapy for metastatic cancer.
Michael H Kershaw, Jacob T Jackson, Nicole M Haynes, Michele W L Teng, Maria Moeller

J Immunol· August 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunotherapy of cancer using systemically delivered gene-modified human T lymphocytes.
Michele W L Teng, Michael H Kershaw, Maria Moeller, Mark J Smyth, Phillip K Darcy

Hum Gene Ther· July 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A functional role for CD28 costimulation in tumor recognition by single-chain receptor-modified T cells.
Maria Moeller, Nicole M Haynes, Joseph A Trapani, Michele W L Teng, Jacob T Jackson

Cancer Gene Ther· May 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis